iDimerize inducible protein dimerization in vivo
Many in vitro applications for chemical-induced dimerization (CID) have progressed into transgenic animals. The B/B Homodimerizer (AP20187) has been the most widely used in vivo, and typically investigators have used doses of 0.5–10 mg per kg for each injection. At this dosage, 5 mg of dimerizer is sufficient for 20–400 injections for a 25-gram mouse. However, the exact dose and treatment must be determined empirically for each experiment.
Many in vitro applications for chemical-induced dimerization (CID) have progressed into transgenic animals. The B/B Homodimerizer (AP20187) has been the most widely used in vivo, and typically investigators have used doses of 0.5–10 mg per kg for each injection. At this dosage, 5 mg of dimerizer is sufficient for 20–400 injections for a 25-gram mouse. However, the exact dose and treatment must be determined empirically for each experiment.
Examples of in vivo mouse models for disease
- The MaFIA mouse model
Macrophages are believed to play an important role in tumor development and progression. The Macrophage Fas-Induced Apoptosis (MaFIA) mouse is a widely adopted mouse model that allows for selective removal of macrophages through apoptosis (Burnett et al. 2004). The mechanism involves expression of a fas-DmrB fusion protein from a myeloid-specific promoter and its induced trimerization with the B/B Homodimerizer (AP20187). Trimerization of the fas death domain activates the caspase 8 pathway and leads to macrophage ablation in MaFIA mice.
- Studying the roles of FGF receptor subtypes in prostate cancer
Prostate-specific expression of inducible versions of two subtypes of fibroblast growth factor receptor, FGFR-1 and FGFR-2, showed that only FGFR-1-induced neoplasia/hyperplasia in the prostate—implying its role in early prostate cancer development (Freeman et al. 2003). This mouse model can be used to test drug candidates that block the effects of FGFR1 dimerization.
Overview
- Small molecules used for chemical-induced dimerization (CID)
- Larger 5-mg and 25-mg sizes for in vivo use
- B/B Homodimerizer is identical to AP20187
- A/C Heterodimerizer is identical to AP21967
- Used to activate pathways or events that are controlled by protein-protein interactions
More Information
References
Burnett, S. H. et al. Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J. Leukoc. Biol. 75(4):612–623 (2004).
Freeman, K. W. et al. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Cancer Res. 63(23):8256–8563 (2003).
Additional product information
Please see the product's Certificate of Analysis for information about storage conditions, product components, and technical specifications. Please see the Kit Components List to determine kit components. Certificates of Analysis and Kit Components Lists are located under the Documents tab.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.